ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • C1q-Fixing Human Leukocyte Antigen Antibodies Identified by a C1q Assay Are Associated with Acute and Chronic Rejection in HLA-IgG Positive Kidney Transplant Recipients

    E. Oh, K. Park, Y. Kim, B. Chung, C. Yang

  • C1q-Fixing Human Leukocyte Antigen Assay for Chronic Antibody-Mediated Rejection in Renal Transplant Recipients

    K. Kai, I. Tsutomu, M. Yashuo, Y. Ogawa, I. Koyama, I. Makajima, S. Fuchinoue

  • C4d as a Good Marker of Acute Humoral Rejection in Small Bowel Transplantation

    M. Rabant, L. Petit, N. Brousse, P. Barbet, J. Duong Van Huyen, C. Chardot, O. Goulet, F. Lacaille, D. Canioni

  • C4d Staining Is an Independent Risk Factor of Graft Loss for Renal Allograft Failure in Patients with Acute Antibody-Mediated Rejection

    A. Moktefi, M. Matignon, C. Suberbielle-Boissel, D. Charron, P. Lang, D. Desvaux, P. Grimbert

  • Calcineurin Inhibitors in HLA Identical Living Related Donor Kidney Transplantation

    P. Verghese, T. Dunn, S. Chinnakotla, K. Gillingham, A. Matas, M. Mauer

  • Calcineurin Polymorphisms Associate with FK506 Dosage and Incidence of BK Viremia in Kidney Transplant Recipients

    M. Horwath, T. Reignier, R. Stone, M. Yap, T. Shah, R. Naraghi, I. Hutchinson

  • Calculated Panel Reactive Antibody (CPRA) after 2.5 Years: More Extremely Sensitized Kidney Waitlist Registrants but Fewer Organ Refusals for a Positive Crossmatch

    L. Baxter-Lowe, A. Kucheryavaya, D. Tyan, N. Reinsmoen

  • Can the Risk of Cancer Transmission from Organ Donors Be Eliminated?

    R. Desai, D. Collett, C. Watson, P. Johnson, T. Evans, J. Neuberger

  • Candidate to Renal Transplant Evaluation: Difficulties in the Access to the Waiting List

    M. Ureña, H. Petrone, M. Frapiccini

  • Carbapenem Resistant Klebsiella Pneumoniae (CRKP) Infection in Solid Organ Transplant Recipients (SOT): A Single Center Analysis

    P. Grossi, A. Mularoni, M. Campanella, G. Vizzini, P. Conaldi, B. Gridelli

  • Cardiac Allograft Prolongation by Autologous CD117+ Progenitor Cells Requires CD11b Expression from within the CD117+ Cellular Inoculum

    T. Grazia, R. Plenter, C. Lin, R. Gill, M. Zamora

  • Cardiac Improvement Is Even Better in Diabetic End-Stage Renal Patients after Kidney Transplantation

    U. Cakir, I. Berber, E. Gurluler, N. Gures, A. Alim, A. Gurkan

  • Cardiac Surgery in Cirrhotic Patients: Should It Be Done Simultaneously or after Liver Transplantation?

    J. Fan, Z. Su, S. Nishida, A. Tekin, G. Selvaggi, A. Tzakis

  • Cardiopulmonary Exercise Testing for Cardiac Risk Assessment Prior to Kidney Transplantation

    H. Chakkera, S. Roy, E. Steidley, A. Kalya, Gopalan, K. Reddy, D. Mulligan, R. Heilman, W. Hewitt, H. Khamash, J. Huskey, A. Moss, N. Katariya, R. Scott

  • Cardiovascular Disease and Kidney Disease Progression in Kidney Transplant Recipients

    A. John, D. Weiner, M. Carpenter, L. Hunsicker, J. Kusek, M. Pfeffer, S. Solomon, M. Weir, A. Levey

  • Cardiovascular Disease Markers in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Everolimus

    R. Schiavelli, C. Cuevas, E. Alvarenga, M. Ponte, A. Otero, F. Margulis

  • Cardiovascular Risk Profile in Children after Renal Transplantation – Introducing the 4C-T Sub-Study

    A. Melk, D. Kracht, A. Doyon, R. Zeller, M. Litwin, A. Duzowa, B. Sözeri, A. Bayzit, S. Caliskan, E. Wuehl, F. Schaefer, B. Schmidt

  • Cause of Progression in Failing Kidney Transplants with Diseases Is Parenchymal Injury, Not Fibrosis, The

    K. Famulski, J. Revee, P. Halloran

  • Causes of Kidney Allograft Loss and Death in the United States, 2000-2010

    J. Snyder, A. Matas, S. Leppke, A. Israni, B. Kasiske

  • Causes of Kidney Transplant Failure: Specific Diseases Versus Non-Specific Injury, The

    M. Naesens, D. Kuypers, K. De Vusser, Y. Vanrenterghem, E. Lerut

  • Causes of Rejection and Non Utilization of Live Liver Donors: A Single Center Experience

    S. Kashkoush, M. Akhtar, B. Hegab, S. Alshlwi, W. O'Hali, K. Abdullah

  • CCR2 Dependent Migration Is Absolutely Required for Myeloid Suppressor Cells To Protect Cell Transplants

    J. Qin, Y. Arakawa, J. Fung, S. Qian, L. Lu

  • CD137 Signaling in Regulatory NK Cells Is Protective Against Liver Ischemia-Reperfusion Injury

    J. Lee, A. Kim, H. Kim, S. Park, S. Koo, H. Cho, B. Kwon

  • CD137, a Marker To Detect the Total Alloreactive T Cell Compartment?

    N. Litjens, E. de Wit, C. Baan, M. Betjes

  • CD3 Antibody-Induced Transplant Tolerance Relies on In Situ TGF-Beta and PD-1 Signaling in T Cells

    M. Baas, A. Besançon, C. Kuhn, C. Mangez, F. Valette, T. Goncalves, L. Chatenoud, S. You

  • CD39 Regulates the Activation of Liver DC and Protects Against Liver Transplant Ischemic Reperfusion Injury

    O. Yoshida, S. Kimura, S. Robson, N. Murase, A. Thomson

  • CD4+ but Not CD8+ Memory T Cells Escape Granzyme B Mediated Regulation by DN-Treg

    Y. Su, X. Huang, D. Lian, W. Min, A. Jevnikar, Z. Zhang

  • CD4+ T Cell Differentiation and Belatacept Resistant Rejection

    J. Espinosa, J. Cheeseman, A. Mehta, L. Stempora, R. Townsend, A. Kirk

  • CD40 Gene Silencing Prevents Warm Renal Ischemia-Reperfusion Injury through Anti-Inflammatory Effects

    L. de Ramon, E. Ripoll, L. Luzardo, A. Merino, N. Lloberas, J. Cruzado, J. Grinyó, J. Torras

  • CD40-Dependent Help by CD4 T Cells Is Required for CD8 T Cell Recovery after Antithymocyte Globulin Lymphoablation

    K. Ayasoufi, X. Wang, H. Yu, A. Valujskikh

  • CD68 Positive Glomerulitis Predicts the Development of Transplant Glomerulopathy in Patients with Cellular Rejection

    M. Willicombe, C. Roufosse, P. Brookes, J. Galliford, A. McLean, T. Cook, D. Taube

  • CD8+ Cytotoxic T Cells Inhibit Alloantibody Production by Killing Alloprimed B Cells

    J. Zimmerer, T. Pham, K. Tobin, V. Sanders, G. Bumgarder

  • CD8+TCR- Bone Marrow Facilitating Cells Induce Generation of IL-10-Producing Type 1 Regulatory T Cells In Vitro: A Critical Role for DOCK2 and Cell-Contact

    Y. Wen, Y. Huang, M. Elliott, D. Corbin, T. Miller, Y. Fukui, S. Ildstad

  • Cell Necrosis and Immune Activation: Does Injury Alter Acquired Alloimmunity?

    S. Hashmi, M. Ford, C. Larsen, A. Kirk

  • Central Role of Mitochondrial Energy Metabolism in Foxp3+ Treg Cell Function and Allograft Survival

    U. Beier, T. Akimova, H. Xiao, C. Sims, A. Angelin, L. Wang, Y. Liu, J. Baur, D. Wallace, W. Hancock

  • Challenges in Safety Managing the Pain in Living Liver Donors

    D. Ladner, K. Waitzman, T. Strenski, E. Pomfret, M. Simpson, R. Brown, R. Fisher, R. Kang, T. Berzins, A. Daud, J. Holl, D. Woods

  • Change in Glomerular Filtration Rate (GFR) in the First Year Post Liver Transplant

    W. Bush, R. Mangus, A. Lutz, J. Fridell, R. Vianna, C. Kubal, A. Tector

  • Change of Blood Pressure and Circadian Rhythm after Kidney Transplantation in End Stage Renal Disease Patients, The

    M. Lee, G. An, Y. Cho, H. Whang, J. Kim, B. Chung, B. Choi, C. Park, Y. Kim, C. Yang

  • Change of Single-Kidney Glomerular Filtration Rate in Kidney Donors after Kidney Donation, The

    G. An, B. Chung, J. Kim, I. Moon, C. Park, Y. Kim, C. Yang, B. Choi

  • Characteristics and Outcomes of Resistant Cytomegalovirus (CMV) Disease in Solid Organ Transplant (SOT) Patients

    P. Chong, P. Deziel, R. Razonable

  • Characteristics of Abdominal Wall Rejection after Intestinal and Abdominal Wall Transplantation

    B. Allin, C. Ceresa, G. Casey, O. Espinoza, T. McPherson, S. Reddy, S. Sinha, P. Friend, A. Vaidya

  • Characterization of Different Gene Families Encoding for Pro-Apoptotic and Anti-Apoptotic as Well as Genes Encoding for Oxidative Stress Induced Cell Damage in Organ Donation: An Animal Study

    P. Stiegler, M. Sereinigg, A. Puntschart, A. Bradatsch, S. Stanzer, E. Stdelmeyer, I. Wiederstein-Grasser, F. Iberer, K. Tscheliessnigg, V. Stadlbauer

  • Characterization of Human CD8+/TCR-/CD56dim/- Facilitating Cells In Vivo and In Vitro

    Y. Huang, M. Elliott, T. Miller, L. Bozulic, D. Corbin, Y. Wen, H. Xu, S. Ildstad

  • Characterization of Human Monocyte Subsets

    L. Boyette, C. Macedo, B. Elinoff, D. Metes, F. Lakkis

  • Characterization of Novel Human Transitional B Cell Subsets and Their Significance in Renal Transplantation

    A. Cherukuri, A. Salama, C. Carter, B. Clark, D. Rothstein, R. Baker

  • Characterization of the Immune Response after Intravenous Infusion of Mesenchymal Stem Cells

    M. Hoogduijn, M. Roemeling-van Rhijn, A. Engela, S. Korevaar, F. Mensah, M. Franquesa, R. de Bruin, M. Betjes, W. Weimar, C. Baan

  • Chemokine Responses as Surrogates of CMV Cell-Mediated Immunity and Predictors of Outcomes in Transplant Recipients

    L. Lisboa, A. Egli, D. O'Shea, S. Prabhakaran, V. Roth, S. Husain, D. Kumar, A. Humar

  • Children Develop De Novo Anti-HLA Antibodies (Abs) Following Kidney Transplantation at a Higher Incidence Than Adults: An Analysis of the NIH CTOT/CCTPT-02 Study

    W. Harmon, I. Guleria, D. Ikle, B. Armstrong, L. Spaneas, Y. Morrison, N. Bridges, M. Sayegh, A. Chandraker

  • Chimeric Antibody Against LFA-1 Does Not Synergize with Belatacept in Primate Renal Transplantation, A

    D. Anderson, F. Leopardi, N. Turgeon, E. Strobert, J. Jenkins, R. Wang, K. Reimann, C. Larsen, A. Kirk

  • Chimerism and Tolerance without GVHD in Mismatched Recipients of Combined Hematopoietic Stem Cell/Kidney Transplants: Donor-Specific Hyporeactivity Is Not a Reliable Biomarker for Tolerance

    J. Leventhal, M. Abecassis, J. Miller, L. Gallon, K. Ravindra, D. Tollerud, L. Bozulic, B. King, M. Elliott, G. Herzig, R. Herzig, S. Ildstad

  • Choice of Induction Therapy in Kidney Transplant: It’s Race Not PRA

    N. Pilch, D. Taber, B. Thomas, S. Denmark, A. Lin, J. McGillicuddy, C. Bratton, P. Baliga, K. Chavin

  • Chronic Opioid Usage Early after Kidney Transplantation

    S. Kulshrestha, F. Barrantes, M. Kommareddi, M. Samaniego-Picota, F. Luan

  • Cigarette Smoking in Living Kidney Donors and Graft Survival

    S. Waits, K. Sheetz, M. Terjimanian, K. Barnhart, M. Englesbe

  • Ciprofloxacin Combined with SMZ/TMP Prophylaxis Reduces the Incidence of UTIs Following Kidney Transplantation

    D. Wojciechowski, S. Chandran

  • Circulating MicroRNAs Correlate with Diabetic Nephropathy and Systemic Microvascular Damage and Normalize after Simultaneous Pancreas-Kidney Transplantation

    R. Bijkerk, M. Khairoun, J. Duijs, K. ter Horst, A. de Vries, E. de Koning, J. de Fijter, T. Rabelink, A. van Zonneveld, M. Reinders

  • CKD-EPI (Cr+Cystatin C) Is a Vastly More Precise Formula in Kidney Transplant Recipients, The

    A. Kukla, N. Issa, B. Morgan, S. Jackson, A. Matas, M. Mauer, H. Ibrahim

  • Class I HLA Mismatches Increase Risk of Acute Rejection, Graft Loss and Formation of De Novo Class II Alloantibody

    E. Casey, M. Gandhi, P. Dean, M. Stegall, F. Cosio

  • Classification of Kidney Transplant Recipients Using a Combination of Estimated GFR and Albuminuria Reflects Prognosis

    H. Talreja, A. Akbari, G. Knoll, C. White

  • Clinical and Mechanistic Outcomes of Photopheresis after Heart Transplantation

    J. Kobashigawa, J. Watanabe, H. Shafi, J. Patel, M. Kittleson, S. Jordan, E. Klapper, M. Toyoda

  • Clinical and Mechanistic Study of How Innate Immunity Gene Polymorphisms Can Affect Influenza Vaccine Responses Post-Transplant, A

    A. Egli, D. Santer, D. O'Shea, A. Baluch, M. Joyce, L. Lisboa, L. Tyrrell, M. Houghton, A. Humar, D. Kumar

  • Clinical Application of Acoustic Radiation Force Impulse in Donor Kidney Compared with Biopsy Results: A Preliminary Report

    A. Lee, D. Joo, Y. Oh, H. Jeong, S. Lee, B. Kim, K. Huh, M. Kim, Y. Kim, K. Park

  • Clinical Features of Patients with Steatohepatitis-Associated Hepatocellular Carcinoma

    A. Zarrinpar, V. Agopian, R. Busuttil

  • Clinical Impact and Evolution of Humoral Immunity in a Randomized Multicenter Trial of Steroid Avoidance in Pediatric Renal Transplantation, The

    M. Sarwal, A. Chadhuri, M. Ozawa, M. Everly, R. Ettenger, V. Dharnidharka, M. Benfield, R. Mathias, A. Portale, R. McDonald, W. Harmon, D. Kershaw, V. Vehaskari, E. Kamil, H. Baluarte, B. Warady, T. Sigdel, H. Szu-chuan, H. Dai, M. Naesens, J. Waskerwitz, O. Salvatierra, P. Terasaki

  • Clinical Impact of an ACE Insertion/Deletion and Kinin B2 Receptor +9/-9 Polymorphisms in the Prognosis of Renal Transplantation

    C. Amorim, S. Almeida, P. Gomes, R. Bacurau, N. Camara, R. Araujo

  • Clinical Outcome of Living Donor Liver Transplantation in Patient with Hepatocellular Carcinoma and Impact to the Various Criteria

    D. Kim, G. Na, T. Hong, Y. Yoo

  • Clinical Outcomes in a Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose Study of ASKP1240 in De Novo Kidney Transplantation

    F. Vincenti, H. Yang, G. Klintmalm, S. Steinberg, L. Wang, W. Zhang, A. Conkle, P. Blahunka, R. First, J. Holman

  • Clinical Outcomes in Sensitized Heart Transplant Patients Bridged with Left Ventricular Assist Devices

    A. Aggarwal, A. Gause, C. Nguyen, I. Balanlayos, G. Bhat

  • Clinical Outcomes of Paired Kidney Exchange for Highly Sensitized Renal Transplant Recipients

    M. Grafals, M. Cooper, J. Verbesey, J. Vucci, B. Javaid, O. Timofeeva, S. Rosen-Bronson

  • Clinical Pharmacokinetics of Once-Daily Prolonged-Release Tacrolimus (Graceptor) in De Novo Kidney Transplantation

    Y. Nakagawa, K. Saito, M. Ikeda, M. Tasaki, K. Takahashi

  • Clinical Presentation and Outcomes of Transplant Glomerulopathy in Hepatitis C Positive Compared to Hepatitis C Negative Patients after Renal Transplantation

    S. Alexandru, A. Sevillano, L. Garcia-Puente, I. Bengoa, E. Gonzalez, M. Serrano, J. Martinez-Flores, A. Serrano, A. Andres, M. Martinez, J. Morales

  • Clinical Results of Combined and Sequential Liver-Kidney Transplantation: A Single Center Experience

    F. Simonato, G. Daidola, G. Tognarelli, E. Gallo, M. Burdese, V. Cantaluppi, G. Segoloni, L. Biancone

  • Clinical Risk Stratification Predicts Ischemic Cardiovascular Complications after Kidney Transplantation with High Sensitivity and Specificity

    N. Townamchai, B. Lee, A. Chandraker

  • Clinical Significance of Protocol Biopsy at Three Months after Kidney Transplantation: A Single Center Experience

    Y. Hong, G. Ahn, Y. Cho, M. Lee, J. Kim, H. Whang, B. Chung, B. Choi, C. Park, Y. Kim, C. Yang

  • Clinicopathological Analysis of Persistent Hyperparathyroidism after Kidney Transplantation in Long-Term Dialysis Patients

    M. Nakamura, H. Shirai, K. Tanaka, Y. Marui, S. Tomikawa

  • Clostridium difficile Infection in Lung Transplant Recipients during the Modern Era of PCR Testing

    J. Lee, D. Tsapepas, J. McDermott, S. Martin, A. Anamisis, K. Fester, J. Powell, J. Scheffert

  • CMV and Allopeptide Crossrecognition Causes Graft Endothelial Cell Injury Mediated by CMV-Committed HLA-E Restricted CD8+T Cells

    B. Charreau, M. Allard, P. Tonnerre, S. Nedellec, R. Oger, A. Morice, Y. Guilloux, E. Chalmeau, N. Gervois

  • CMV Serostatus Correlation with Early Kidney Allograft Transcriptome Change in the GOCAR Cohort

    A. Le Page, W. Zhang, B. Murphy, B. Nankivell, J. Chapman, P. O'Connell, S. Alexander, W. Rawlinson

  • CMV Vaccine Prevents Accelerated Chronic Rejection in CMV-Naive Recipients of Infected Allograft Hearts

    D. Streblow, Y. Hwee, C. Kreklywich, T. Andoh, M. Denton, M. Slifka, I. Messauodi, S. Orloff

  • CNI-Related Renal Impairment in Liver Transplantation: A Comparison of Cyclosporine and Tacrolimus-Based Regimens

    A. Davie, V. Damera, F. Bianic, J. Ricci, P. Bernhardt, S. Gokhale, J. Lake

  • Cohort Study of Solid Organ Transplant Recipients Who Develop Malignancy: Risk of Subsequent Malignancy on mTOR vs. Non-mTOR Regimens, A

    P. Karia, J. Azzi, E. Heher, C. Schmults

  • Collapsing Glomerulopathy of the Kidney Allograft: Is It Different from Idiopathic Collapsing Glomerulopathy of Native Kidney?

    L. Kamal, T. Muthukumar, D. Dadhania, C. Hartono, D. Serur, M. Suthanthiran, S. Seshan

  • Colorectal Surgery after Kidney Transplant: Characteristics of Early vs. Late Post-Transplant Interventions

    J. Lee, M. Kwaan, A. Sirany, G. Melton, R. Madoff, T. Dunn

  • Combination of Anti-BTLA Antibody (6B2) and Anti-PD-1 Antibody (PIM-2) Induced Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allograft

    X. Jin, M. Uchiyama, L. Yu, H. Bashuda, H. Yagita, M. Niimi

  • Combination of Renal Dysfunction Plus Proteinuria at One Year Is a Strong Predictor of Early Graft Loss after Renal Transplantation. A National Spanish Study, The

    J. Munoz-Robles, L. Samaniego, R. Marcén, A. Andrés, D. Serón, J. Morales

  • Combination of Steroids and Methotrexate with Costimulation Blockade Prolongs Renal Allograft Survival, The

    D. Anderson, D. Lo, F. Leopardi, N. Turgeon, E. Strobert, J. Jenkins, C. Larsen, A. Kirk

  • Combined Costimulatory and OX40L Blockade Significantly Prolongs Transplant Survival in Mice and Non-Human Primates

    W. Kitchens, W. Wakwe, C. Breeden, H. Yagita, A. Kirk, C. Larsen, M. Fuentes, M. Ford, A. Adams

  • Combined Induction Therapy with Rabbit Antithymocyte Globulin (rATG) and Rituximab (RTX) in Highly Sensitized Kidney Recipients: Long-Term Outcomes

    M. Laftavi, S. Patel, R. Kohli, M. Zachariah, L. Feng, M. Said, M. Dayton, O. Pankewycz

  • Combined Liver-Kidney Transplantation: Simultaneous Versus Delayed Transplantation of the Kidney Graft

    B. Ekser, W. Goggins, R. Mangus, A. Shah, T. Beduschi, C. Kubal, J. Fridell, J. Powelson, R. Vianna, A. Tector

  • Combined Liver, Small Bowel, Pancreas and Kidney Transplantation (LSBPKTx): Single Center Experience of over a Decade

    L. Bathla, W. Grant, D. Mercer, L. Vargas, A. Langnas

  • Combined Lung and Liver Transplantation: Analysis of a Single-Center Experience

    S. Yi, S. Gordon Burroughs, M. Loebe, S. Scheinin, H. Seethamraju, M. Boktour, A. Gaber, R. Ghobrial

  • Common Rejection Module (CRM) across Multiple Transplant Organs Identifies Novel Therapeutics for Treatment of Acute Rejection in Solid Organ Transplantation, A

    S. Roedder, P. Khatri, N. Kimura, K. De Vusser, A. Morgan, Y. Gong, M. Fischbein, R. Robbins, M. Naesens, A. Butte, M. Sarwal

  • Comparable Risk of End-Stage Renal Disease (ESRD) in Liver Transplant Alone (LTA) and Simultaneous Liver Kidney (SLK) Recipients Who Had Pre-LT Kidney Biopsy for Renal Dysfunction or Proteinuria

    H. Wadei, M. Mai, M. Prendergast, A. Keaveny, S. Pungpapong, T. Gonwa

  • Comparable Waiting Time for Highly Sensitized Patients Awaiting Heart Transplant Using Desensitization Therapy and the Virtual Crossmatch

    J. Kobashigawa, M. Kittleson, M. Rafiei, A. Osborne, D. Chang, L. Czer, N. Reinsmoen, J. Patel

  • Comparative Ability of Different Metabolic Syndrome Definitions To Predict Major Adverse Cardiovascular Events after Kidney Transplantation

    G. Prasad, M. Huang, S. Silver, A. Allawati, L. Rapi, M. Nash, J. Zaltzman

  • Comparative Effectiveness of Rabbit Anti-Thymocyte Globulin vs. Interleukin-2 Receptor Blockers in Deceased Donor Kidney Transplants with Delayed Graft Function, The

    A. Oweis, J. Zaltzman, J. Kim

  • Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment

    T. Nozaki, H. Ishida, T. Shimizu, K. Omoto, D. Toki, H. Shirakawa, K. Tanabe

  • Comparing Outcomes from Pancreata from Donation after Circulatory Death to Donation after Brain Death in a Small Rural Program

    A. Paine, D. Moon, M. Taylor, J. Yamaguchi, A. Di Carlo

  • Comparing Outcomes of Kidney Transplantation in Octogenarians to Septuagenarians

    A. Paine, D. Moon, V. Sigounas, M. Taylor, J. Yamaguchi, A. Di Carlo

  • Comparison of 20-Year Patient and Graft Survival for All Types of Solid Organ Transplants (Txs)

    R. Gruessner, T. Jie, M. Porubsky, A. Rana, A. Gruessner

  • Comparison of Baseline and Day 28 Post Transplant Renal Allograft Samples from the CTOT-10 Belatacept Study

    Y. Suessmuth, L. Stempora, B. Johnson, J. Cheeseman, Y. Morrison, N. Bridges, D. Ikle, S. Tomlanovich, P. Stock, R. Mannon, K. Newell, C. Larsen, A. Mehta

  • Comparison of Creatinine Reduction Ratio on Day 2 with 6-Hour Post-Operative Creatinine Reduction in Defining Early Renal Allograft Function

    S. Patel, R. Knight, T. Lawrecki, B. Masters, P. Tannous, A. Gaber

  • Comparison of Efficacy and Mechanism of Intact and Fc-Modified Anti-CD154 Antibodies in Tolerance Induction

    D. Pinelli, D. Liu, M. Wagener, A. Suri, S. Nadler, M. Ford

  • Comparison of Estimated Glomerular Filtration Rate Using Cystatin C Versus Creatinine in Pediatric Renal Transplant Patients

    H. Pizzo, J. Nguyen, G. Schwartz, R. Ettenger, E. Tsai

  • Comparison of Everolimus Pharmacokinetics and Pharmacodynamics between Ethnicities

    D. Taber, L. Belk, N. Pilch, J. McGillicuddy, C. Bratton, K. Chavin, P. Baliga

  • Comparison of Gene Expression in Heart Beating and Non Heart Beating Donor Kidney, A

    T. Saat, D. Susa, H. Roest, N. Kok, S. van den Engel, J. IJzermans, R. de Bruin

  • Comparison of Health Status and Quality of Life of Related Versus Paid Unrelated Living Kidney Donors: A Single Center Experience from Iran

    M. Fallahzadeh, L. Jafari, M. Sagheb, J. Roozbeh, N. Singh, M. Shokouh-Amiri, S. Malekhosseini

  • Comparison of Hepatitis C Recurrence in Orthotopic Liver Transplant Recipients Receiving Antibody Induction Versus No Antibody Induction

    S. Patel, P. West-Thielke, H. Jeon, E. Benedetti, J. Thielke

  • Comparison of Histamine Receptor Antagonists Versus Proton Pump Inhibitor Stress Ulcer Prophylaxis in Kidney Transplant Recipients, A

    G. Morris, K. Hardinger, D. Tsapepas, E. Tichy

  • Comparison of Patient and Graft Outcomes of HUS Kidney Transplants (KT) with and without Post Transplant Recurrence: A 10 Year Retrospective Analysis

    A. Santos, X. Wen, M. Casey, C. Bucci, R. Aiyer, I. Zendejas, S. Rehman

  • Comparison of Pediatric En-Bloc Renal Allograft Growth and Function for Donors Less Than One Year of Age with Older Pediatric Donors

    N. Rowe, M. Dion, J. Shum, C. Weernink, A. Sener, P. Luke

  • Comparison of Pharmacokinetics of Once- and Twice-Daily Tacrolimus in Pediatric Kidney Transplant Recipients

    S. Shishido, Y. Hyoudo, H. Nihei, Y. Hamasaki, M. Muramatsu, Y. Niitsu, T. Kawamura, K. Sakai, A. Aikawa

  • Comparison of Protein A-Immuno-Adsorption and Conventional Plasma Exchanges for Anti-HLA Desensitization

    N. Maillard, I. Masson, M. Mehdi, E. Alamartine, C. Mariat

  • Comparison of QuantiFERON-TB Gold with Tuberculin Skin Test for Detecting Latent Tuberculosis Infection before Kidney Transplantation

    C. Kim, H. Jung, K. Kim, J. Lim, O. Kwon, J. Choi, J. Cho, S. Park, Y. Kim

  • Comparison of Resource Utilization between Three Induction Regimens in Kidney Transplant Recipients

    M. Bunke, E. Chua, N. Bhensdadia, M. Salazar, M. Posadas, D. Taber

  • Comparison of Transumbilical and Conventional Laparoscopic Donor Nephrectomy

    M. Minz, V. Kaji, A. Sharma, S. Singh, D. Kenwar

  • Comparison of Voclosporin and Tacrolimus 1 Year Outcomes as Predicted by PKPD in the PROMISE Trial, A

    R. Alloway, R. Bloom, R. Gaston, M. Goggins, P. Mayo, S. Busque

  • Compartmentalization of Acute Versus Chronic Rejection in Cardiac Allografts

    A. Kaul, H. Yu, N. Dvorina, W. Baldwin

  • Complement Blockade Prevents Delayed Graft Function in a Non-Human Primate Model of Kidney Allo-Transplantation

    J. Danobeitia, L. Zitur, E. Van Amersfoort, A. D'Alessandro, B. Oortwijn, X. Ma, S. Capuano, K. Brunner, J. Torrealba, L. Fernandez

  • Complement Component 3 (C3) Participates in Induction of Myeloid Suppressor Cells

    C. Hsieh, H. Chou, L. Wang, F. Lin, J. Qin, J. Fung, L. Lu, S. Qian

  • Complement Fixing HLA Antibodies Predict Outcome in HLA Incompatible Renal Transplantation

    C. Clarke, P. Brookes, C. Lawrence, M. Willicombe, P. Dodd, E. Santos-Nunez, J. Galliford, D. Taube

  • Complement-Activating DSA: Which Assay in Which Setting?

    C. Lawrence, M. Willicombe, P. Brookes, E. Santos-Nunez, C. Roufosse, A. Warrens, D. Taube

  • Complement-Activating Low-Level Preformed Donor-Specific Antibodies Detected by C1qScreen™ Predict Early Antibody-Mediated Rejection in Renal Allografts

    C. Lawrence, M. Willicombe, P. Brookes, C. Clarke, E. Santos-Nunez, C. Roufosse, A. Warrens, D. Taube

  • Complex Host MicroRNA Response to Cytomegalovirus Infection: A Bench to Bedside Analysis, A

    A. Egli, L. Lisboa, D. O'Shea, V. Emery, A. Asberg, A. Hartmann, D. Kumar, A. Humar

  • Complication Free Heterotopic Cardiac Xenograft Survival by Anti CD40 Antibody Mediated Co-Stimulation Blockade

    A. Singh, P. Corcoran, B. Lewis, R. Hoyt, M. Thomas, M. Eckhaus, C. Mayhew, T. Clark, K. Reimann, D. Ayares, K. Horvath, M. Mohiuddin

  • Composite Score at Time of Kidney Transplantation Predicts Graft Function

    V. Mas, W. Xin, J. Suh, R. Gerhau, A. King, K. Brayman, J. Lee, D. Maluf

  • Comprehensive Analyses of Inhibitory Effects of the mTOR Inhibitor Everolimus on the Differentiation into Subsets of Human T-Helper Cells and B Cells

    Y. Tanaka, M. Yamashita, H. Ohdan

  • Concomitant Azathioprine and Warfarin Warrants Significant Warfarin Dosage Increase

    L. Bowman, K. Bain, J. Hagopian, J. Iuppa, J. Shuster, T. Horwedel

  • Concurrent Silencing of TLR and Kinase Signaling Pathways To Prevent Allograft Rejection in Heart Transplantation

    X. Zhang, D. Lian, X. Zheng, D. Chen, K. Siu, N. Johnston, D. Quan, W. Min

  • Contemporary Analysis of the Effect of Induction Immunosuppression of Survival in Pediatric Lung Transplant Recipients, A

    D. Hayes, Jr., S. Kirkby, A. Wehr, A. Lehman, P. McConnell, M. Galantowicz, R. Higgins, B. Whitson

  • Continuous Coronary Sinus Perfusion for Recovery of Hearts from Non-Heart-Beating Donors

    M. Peltz, S. Brant, M. Cobert, L. West, M. Jessen

  • Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients

    N. Alpay, A. Ozkok, Y. Caliskan, T. Akagun, S. Cinar, G. Deniz, M. Sariyar, A. Yildiz

  • Conversion from TAC-MMF to mTOR-TAC Immunosuppression in Kidney-Pancreas Transplantation Reduces the Incidence of BK Viremia

    R. Knight, S. Patel, J. DeVos, L. Moore, A. Gaber

  • Conversion from Tacrolimus (TAC) to Sirolimus (SRL)-Based Immunosuppressive Regimen in Kidney Transplant Recipients: 2 Years Results

    H. Tedesco, E. Neto, V. Garcia, F. Continieri, D. Carvalho, M. Abbud, J. Medina- Pestana

  • Conversion from Tacrolimus to Sirolimus May Increase the Risk of Cardiovascular Events in Kidney Transplant Recipients

    M. Kim, M. Pavlakis, C. Rogers

  • Conversion to a Sirolimus-Based Regimen Is Associated with Lower Incidence and Faster Resolution of BK Viremia in Low Risk Kidney Transplant Recipients

    F. Tohme, R. Kalil, C. Thomas

  • Cordycepin Inhibits Lipopolysaccharide-Induced Inflammation by the Suppression of the MAPK-IκB-NF-κB Pathways in DCs

    C. Ding, P. Tian, Z. Jin, T. Mao, Y. Li, H. Tian, H. Xiang, X. Pan, X. Ding, W. Xue

  • Coronary Angiography in Asymptomatic Kidney Transplant Candidates?

    C. Lawrence, S. Cruickshank, A. Manoj, S. Mathavakkannan, S. Chandna, S. Fluck, K. Farrington

  • Correlation of Global Copy Number Changes with Micro RNA Expression Profiling Reveals MUC1 as a Marker for HCC Recurrence after Transplant

    C. Barry, C. Whitney-Miller, M. Orloff

  • Correlation of Zero-Time Biopsies in Deceased Renal Transplantation and One Year Graft Function

    A. Matos, N. Camara, L. Requiao-Moura, E. Tonato, M. Souza Durao, E. Ferraz, M. Fregonesi Silva, M. Borreli, D. Malheiros, A. Pacheco-Silva

  • Correlations of In Vitro Islet Potency Tests with Clinical Islet Auto-Transplant Outcome

    K. Papas, M. Bellin, D. Sutherland, J. Kitzmann, E. Avgoustiniatos, A. Gruessner, K. Mueller, A. Balamurugan, P. Rozak, G. Loganathan, T. Suszynski, J. Wilhem, D. Qian, J. Niland, B. Hering

  • Correlations of Postreperfusion Syndrome in Liver Transplant Recipients

    G. Droc, E. Scarlatescu, D. Tomescu, D. Ungureanu, R. Fota, A. Cristea, M. Popescu, I. Popescu

  • Cost Effective Prevention of CMV Infection and Its Long-Term Consequence

    F. Luan, A. Ojo

  • Cost Effectiveness of a Belatacept-Based Regimen in Kidney Transplant Recipients

    V. Caccioppoli, A. MacLasco, K. Chan, R. Gandhi, S. LaBella, L. Somers, C. Rogers

  • Cost Implications of New Kidney Allocation Policy

    M. Schnitzler, A. Israni, S. Gustafson, J. Tuttle-Newhall, K. Lentine, D. Axelrod, N. Salkowski, J. Snyder, B. Kasiske

  • Cost of Sepsis in a Program Utilizing Indefinite Sulfamethoxazole-Trimethoprim Prophylaxis in Renal Transplant Recipients

    T. Horwedel, L. Bowman, D. Brennan

  • Cost-Effectiveness of Hand-Assisted Retroperitoneoscopic Versus Standard Laparoscopic Donor Nephrectomy: A Randomized Study

    K. Klop, N. Kok, S. Janki, L. Dols, F. d'Ancona, E. Adang, J. Grutters, J. IJzermans

  • Course of BK Virus Infection in Renal Transplant Recipients Treated with Cidofovir

    S. Kuten, S. Patel, R. Knight, L. Gaber, A. Gaber

  • Creatinine (Creat) and Cystatin C (CysC) Based Glomerular Filtration Rate (GFR) Estimating Equations Are More Precise Than Creatinine-Only-Based Equations in Former Living Kidney Donors

    N. Issa, A. Kukla, S. Jackson, S. Riad, A. Matas, H. Ibrahim

  • Creatinine as a Marker of Rejection Reversal in Recipients with Post-Treatment Biopsies

    A. Jantz, S. Patel, L. Moore, L. Gaber, R. Knight, A. Gaber

  • Critical Analysis of Death within 1 Year after Liver Transplantation, A

    A. Rana, M. Porubsky, T. Jie, S. Habib, H. Rilo, B. Kaplan, A. Gruessner, R. Gruessner

  • Critical Analysis of Retransplantation within 1 Year after Liver Transplantation, A

    A. Rana, M. Porubsky, T. Jie, S. Habib, H. Rilo, B. Kaplan, A. Gruessner, R. Gruessner

  • Critical Analysis of Valganciclovir Dosing and Renal Function on the Development of CMV Infection in Kidney Transplantation

    M. Posadas Salas, D. Taber, E. Chua, B. Thomas

  • Critical Role of Allograft Infiltrating ROR Gamma t Positive Innate Immune Cells and Hematopoietic Progenitor Cells

    Z. Fan, K. Jung, S. Yun, T. Strom, M. Koulmanda

  • Critical Role of Notch-1 in the Alloimmune Response

    S. Ohori, C. Magee, T. Shimizu, C. Siebel, L. Riella, N. Najafian

  • Critical Role of Notch-2 Signaling in Alloantibody Production

    C. Magee, T. Shimizu, S. Ohori, C. Siebel, N. Najafian, L. Riella

  • Crossmatch Positive Liver Transplantation: Role of Underlying Liver Disease

    C. Kubal, R. Mangus, R. Saxena, A. Lobashevsky, N. Higgins, A. Shah, R. Vianna, J. Fridell, J. Tector

  • CTLA-4 Ig Prevents Chronic Antibody-Mediated Rejection

    B. Oh, J. Kwun, R. Ruhil, A. Gibby, A. Kirk, S. Knechtle, N. Iwakoshi

  • Cumulative Effect of Metabolic Syndrome Components in Predicting Major Adverse Cardiovascular Events after Kidney Transplantation

    G. Prasad, M. Huang, S. Silver, A. Allawati, L. Rapi, M. Nash, J. Zaltzman

  • Cumulative Incidence and Factors Associated with Return to Active Status among Temporarily Inactive Obese Renal Transplant Candidates

    M. Shye, M. Kamgar, A. Mehrnia, S. Bunnapradist, E. Huang

  • Curriculum Thoracic Transplantation (CTTX): Training on Heart and Lung Explantation and Implantation

    M. Barten, H. Bittner, K. Püschel, F. Mohr, T. Karbe

  • Cutaneous Collateral Axonal Sprouting Re-Innervates the Skin Component and Restores Sensation of Denervated Swine Osteomyocutaneous Allografts

    Z. Ibrahim, J. Christensen, C. Lin, K. Sarhane, P. Hauer, M. Polydefkis, S. Schneeberger, D. Cooney, J. Sacks, W. Lee, G. Brandacher

  • Cytokine Measurement by High-Sensitivity Milliplex Assay in Cell Suspensions Obtained during Usual Kidney Allograft Biopsies

    N. Leca, S. Anderson, K. Muczynski

  • Cytomegalovirus and Post-Transplant Cancer: Protection, Predisposition or No Effect?

    R. Desai, D. Collett, J. Neuberger

  • Cytometry Time of Flight (CyTOF) Analysis of Epstein Barr Virus-Specific T Cells in Pediatric Liver Transplant Recipients

    K. Piard-Ruster, S. Krams, C. Esquivel, O. Martinez

Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences